In recent years, pharmaceutical companies have been increasingly developing complex drug formulations to enhance drug efficacy, improve patient compliance, and reduce side effects. These formulations often require precise dosing, specialized delivery mechanisms, and controlled release profiles. Therefore, pharmaceutical packaging has evolved beyond simple blister packs and bottles. The demand for specialized packaging that can preserve the integrity of these complex formulations while ensuring accurate dosing and administration has surged. This shift has opened up opportunities for contract packaging providers who possess the technical expertise to handle these intricate packaging requirements.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-contract-pharmaceutical-packaging-market
Data Bridge Market Research analyzes that the Global Contract Pharmaceutical Packaging Market is expected to reach USD 10,313,375.65 thousand by 2030 from USD 5,900,960.00 thousand in 2022, growing with a substantial CAGR of 7.4% in the forecast period of 2023 to 2030. The impact of complex drug formulations and specialized packaging needs is expected to act as a driver for the growth of the market.
Key Findings of the Study
Impact of Regulatory Compliance and Quality Assurance Demands
The impact of regulatory compliance and quality assurance demands plays a crucial role in driving the growth of the global contract pharmaceutical packaging market. In today's pharmaceutical landscape, stringent regulations and rigorous quality standards are paramount to ensure the safety and efficacy of drugs. As a result, pharmaceutical companies are increasingly outsourcing their packaging needs to specialized contract packaging providers to navigate the complex regulatory landscape efficiently.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Year
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Thousand
|
|
Segments Covered
|
Type (Primary Packaging System, Secondary Packaging System, and Tertiary Packaging System), Raw Material (Plastic & Polymers, Glass, Metals, Paper & Board, Rubber, Cotton, and Others), Application (Transmucosal Drug Delivery Packaging, Pulmonary Drug Delivery Packaging, Nasal Drug Delivery Packaging, Topical Drug Delivery Packaging, Injectable Packaging, Oral Drug Delivery Packaging, and Others)
|
|
Countries Covered
|
U.S., Canada, and Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Belgium, Russia, Turkey, Switzerland, Luxembourg, and Rest of Europe, China, India, Japan, South Korea, Australia and New Zealand, Indonesia, Singapore, Malaysia, Thailand, Philippines, and Rest of Asia-Pacific, Brazil, Argentina, and Rest of South America, United Arab Emirates, South Africa, Egypt, Saudi Arabia, Israel, and Rest of Middle East and Africa
|
|
Market Players Covered
|
AbbVie Inc. (U.S.), PCI Pharma Services (U.S.), Nelipak Corporation (U.S.), Sharp Services, LLC (U.S.), Aphena Pharma Solutions (U.S.), AmeriPac (U.S.), Assemblies Unlimited, Inc. (U.S.), Jones Healthcare Group (Canada), Reed-Lane (U.S.), ROPACK INC. (Canada), Sepha (U.K.), SilganUnicep (U.S.), SternMaid GmbH & Co. KG (Germany), Tjoapack (Netherlands), Tripak Pharmaceuticals (Australia), and Wasdell Packaging Group (U.K.), among others.
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
|
Segment Analysis
The global contract pharmaceutical packaging market is segmented into three notable segments on the basis of type, raw material, and application.
- On the basis of type, the market is segmented into primary packaging system, secondary packaging system, and tertiary packaging system.
In 2023, the primary packaging system segment is expected to dominate the global contract pharmaceutical packaging market
In 2023, the primary packaging system segment is expected to dominate the market with a 35.67% market share because it directly protects and preserves the integrity of individual drug products, ensuring safety and compliance.
- On the basis of raw material, the market is segmented into plastic & polymers, glass, metals, paper & board, rubber, cotton, and others.
In 2023, the plastic and polymers segment is expected to dominate the global contract pharmaceutical packaging market
In 2023, plastic and polymers segment is expected to dominate the market with a 37.06% market share because of the wide usage of plastics in the pharmaceutical packaging system.
- On the basis of application, the market is segmented into transmucosal drug delivery packaging, pulmonary drug delivery packaging, nasal drug delivery packaging, topical drug delivery packaging, injectable packaging, oral drug delivery packaging, and others. In 2023, the transmucosal drug delivery packaging segment is expected to dominate the market with a 36.56% market share.
Major Players
Data Bridge Market Research recognizes the following companies as the major players in the global contract pharmaceutical packaging market that include AbbVie Inc. (U.S.), PCI Pharma Services (U.S.), Nelipak Corporation (U.S.), Sharp Services, LLC (U.S.), Aphena Pharma Solutions (U.S.), AmeriPac (U.S.), Assemblies Unlimited, Inc. (U.S.), Jones Healthcare Group (Canada), Reed-Lane (U.S.), ROPACK INC. (Canada), Sepha (U.K.), SilganUnicep (U.S.), SternMaid GmbH & Co. KG (Germany), Tjoapack (Netherlands), Tripak Pharmaceuticals (Australia), and Wasdell Packaging Group (U.K.), among others.
Market Developments
- In December 2022, Nelipak Corporation established a cutting-edge flexible packaging production site in Winston-Salem, North Carolina. This strategic move will extend Nelipak's healthcare packaging capabilities from Europe to the Americas, catering to the increasing demand in the region. The 110,000 square-foot facility, equipped with ISO-7 clean room space and ISO 13485 certification, represents a USD 20 million investment and is projected to generate approximately 80 jobs over the next five years.
- In October 2022, Aphena Pharma Solutions Inc. announced that its USD 20 million expansion and renovation, which began mid-2019 in Cookeville, Tennessee, is now complete, adding a large amount of available solid dose packaging capacity. This added space has allowed Aphena to grow the company’s bottle and blister packaging capacity largely, with four additional high-speed bottling lines and two additional high-speed blister lines for solid-based products, making Aphena a strong strategic growth partner for any generic or OTC pharmaceutical company.
- In September 2022, Nelipak Corporation achieved International Sustainability and Carbon Certification (ISCC) PLUS for its facilities in Phoenix, AZ, and Whitehall, PA. This recognition highlighted Nelipak's dedication to sustainable practices, utilizing a circular supply chain by incorporating recycled and bio-based materials.
- In October 2020, Alnylam Pharmaceuticals partnered with Sharp to package its approved RNAi therapeutic products in European markets. Sharp's Hamont-Achel site in Belgium will handle the packaging for Alnylam's offerings across European countries. This collaboration marked a significant international investment for Alnylam in Belgium, aligning with their strategy to enhance their presence in the region and establish it as a key hub for operations.
- In May 2020, Sharp, acquired a pharmaceutical packaging facility in Macungie, Pennsylvania. This facility, formerly owned by Quality Packaging Specialists International, LLC (QPSI), spans 160,000 sq. ft. and is fully equipped for primary and secondary pharmaceutical packaging, including bottling, blistering, vial labeling, medical device kitting, and serialization services. The strategic acquisition catered to escalating client volume demands, bolstering Sharp's capacity to provide efficient packaging solutions.
Regional Analysis
Geographically, the countries covered in the global contract pharmaceutical packaging market are U.S., Canada, and Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Belgium, Russia, Turkey, Switzerland, Luxembourg, and Rest of Europe, China, India, Japan, South Korea, Australia and New Zealand, Indonesia, Singapore, Malaysia, Thailand, Philippines, and Rest of Asia-Pacific, Brazil, Argentina, and Rest of South America, United Arab Emirates, South Africa, Egypt, Saudi Arabia, Israel, and Rest of Middle East and Africa.
As per Data Bridge Market Research analysis:
North America is the dominant region in the global contract pharmaceutical packaging market
North America region is expected to dominate the global contract pharmaceutical packaging market due to its advanced infrastructure and established pharmaceutical industry that enables efficient production and distribution for pharmaceutical packaging needs.
Asia-Pacific is the fastest-growing region in the global contract pharmaceutical packaging market during the forecast period of 2023-2030
Asia-Pacific is the fastest-growing region in the global contract pharmaceutical packaging market due to the cost efficient production capabilities and increasing demand for pharmaceutical products in the region.
For more detailed information about the global contract pharmaceutical packaging market please click here: https://www.databridgemarketresearch.com/reports/global-contract-pharmaceutical-packaging-market
